Teri recently joined the team at the National Hemophilia Foundation to launch the new Pathway to Cures (P2C) venture philanthropy fund focused on investments in companies developing therapies for inheritable blood disorders. Teri has been in the business of commercializing early-stage research results for over 35 years and most recently as the founding managing director of IU Ventures’ Indiana Philanthropic Venture Fund. Teri served as a senior executive for business development for Cold Spring Harbor Laboratory, Mount Sinai School of Medicine in NYC, was the founding chief executive of Cambridge Enterprise Ltd in Cambridge England and a co-founder of ARCH Development Partners an early-stage Midwest venture fund. She was involved in state government in Indiana as a founding member of the Indiana 21st Century Fund and is a Sagamore of the Wabash.